Welcome to visit Zhongnan Medical Journal Press Series journal website!
Zhongnan Medical Journal Press Series of Journals Center for Evidence-Based and Translational Medicine of Wuhan University

The title
  • The title
  • The keywords
  • The author
Submit中文版

HomeArticlesVol 34,2024 No.7Detail

Definition and literature of evidence-based urology: a systematic review

Published on Jul. 30, 2024Total Views: 472 timesTotal Downloads: 193 timesDownloadMobile

Author: WANG Yunyun 1 CHEN Zheng 2 ZHONG Quliang 3 HUANG Xing 4 XU Xiaofeng 5 LI Xiaodong 6, 7 ZI  Hao 1, 8 JIN Yinghui 1 LI Binghui 1 WENG Hong 1, 9, 10 DONG Zhilong 11, 12 ZENG Xiantao 1, 9, 10, 13

Affiliation: 1. Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China 2. Department of Urology, The First Affiliated Hospital of Jinan University, Guangzhou, 510632, China 3. Department of Urology, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China 4. Department of Urology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China 5. Department of Urology, Xianyang Central Hospital, Xianyang 712099, Shaanxi Province, China 6. Department of Urology, The First Affiliated Hospital of Henan University, Kaifeng 475004, Henan Province, China 7. Institutes of Evidence-Based Medicine and Knowledge Translation, Henan University, Kaifeng 475001, Henan Province, China 8. Department of Evidence-Based Medicine, Xiangyang No.1 People’s Hospital Affiliated to Hubei University of Medicine, Xiangyang 441022, Hubei Province, China 9. Zhongnan Medical Journal Press, Zhongnan Hospital of Wuhan University, Wuhan 430071, China 10. Institute of Urology, Wuhan University, Wuhan 430071, China 11. Department of Urology, The Second Hospital of Lanzhou University, Lanzhou 730030, China 12. Gansu Provincial Clinical Research Center for Urological Diseases, Lanzhou 730030, China 13. Hubei Provincial Clinical Research Center for Endourology, Wuhan 430071, China

Keywords: Evidence-based medicine Evidence-based urology Definition Methodology Systematic review

DOI: 10.12173/j.issn.1004-5511.202402068

Reference: Wang YY, Chen Z, Zhong QL, HUANG X, XU XF, LI XD, ZI H, JIN YH, LI BH, WENG H, DONG ZL, ZENG XT. Definition and literature of evidence-based urology: a systematic review[J]. Yixue Xinzhi Zazhi, 2024, 34(7): 725-743. DOI: 10.12173/j.issn.1004-5511.202402068.[Article in Chinese]

  • Abstract
  • Full-text
  • References
Abstract

Objective  To systematically analyze relevant literature on evidence-based urology (EBU) in China and abroad, and to understand their definitions and methodological research status.

Methods  The PubMed, Web of Science, CNKI, Wanfang, VIP Database for Chinese Technical Periodicals, and SinoMed were searched, JD.com and Dangdang.com engines are used to assist retrieval. The search was conducted as of August 9, 2023. The connotation and methodological research characteristics of EBU were extracted, and then used content analysis to integrate the extracted information.

Results  A total of 37 literature were included. There was no literature on the definition of EBU yet, and the research topics involved randomized controlled trials, systematic review, guidelines, evidence grading, Cochrane Library and PubMed database literature retrieval, evidence-based clinical decision-making, etc. 12 articles focused on 11 topics of randomized controlled trials or clinical trials such as subgroup analysis, relative and absolute effects, alternative endpoints; 5 articles introduced 4 themes of systematic review including heterogeneity, publication bias, P-value and confidence interval, and likelihood ratio; 9  literature systematically outlined the key methods of evidence-based medicine and provide evidence support for clinical questions related to the urinary system diseases. In terms of writing format, cases of urinary system diseases were used for explanation.

Conclusion  The definition of EBU has not yet been clarified, but it has a good foundation of development and constructionn, and the theoretical system EBU needs to be further improved. For example, starting with the complexity of the problems emerging in urology, actively proposing new ways of solving them, enriching research evidence types, innovating grading standards, expanding the clinical decision-making methods of EBU, and accelerating the optimization of subject curriculum system and talent cultivation.

Full-text
Please download the PDF version to read the full text: download
References

1. 曾宪涛. 再谈循证医学[J]. 武警医学, 2016, 27(7): 649-654. [Zeng XT. Re-discuss evidence-based medicine[J]. Medical Journal of the Chinese People's Armed Police Forces, 2016, 27(7): 649-654.] DOI: 10.14010/j.cnki.wjyx.2016.07.001.

2. Piramide F, Turri F, Amparore D, et al. Atlas of intracorporeal orthotopic neobladder techniques after robot-assisted radical cystectomy and systematic review of clinical outcomes[J]. Eur Urol, 2024, 85(4): 348-360. DOI: 10.1016/j.eururo.2023.11.017.

3. Wallis CJD, Klaassen Z, Bhindi B, et al. Abiraterone acetate and docetaxel with androgen deprivation therapy in high-risk and metastatic hormone-naïve prostate cancer: a systematic review and network Meta-analysis[J]. Eur Urol, 2018, 73(6): 834-844. DOI: 10.1016/j.eururo.2017.10.002.

4. Tello Royloa C. Diez años de medicina basada en pruebas. Introducción a la urología basada en pruebas [10 years of evidence-based medicine. Introduction to evidence-based urology][J]. Actas Urol Esp, 2003, 27(4): 251-259. DOI: 10.1016/s0210-4806(03)72917-9.

5. Kilpeläinen TP, Tikkinen KAO, Guyatt GH, et al. Evidence-based urology: subgroup analysis in randomized controlled trials[J]. Eur Urol Focus, 2021, 7(6): 1237-1239. DOI: 10.1016/j.euf.2021.10.001.

6. Witte LPW, Tikkinen KAO, Guyatt GH, et al. Evidence-based urology: importance of relative vs absolute effect[J]. Eur Urol Focus, 2021, 7(6): 1226-1229. DOI: 10.1016/j.euf.2021.09.022.

7. Tikkinen KAO, Guyatt GH. Evidence-based urology: introduction to our series of articles[J]. Eur Urol Focus, 2021, 7(6): 1215-1216. DOI: 10.1016/j.euf.2021.09.015.

8. McAlpine K, Lavallée LT, Breau RH. Evidence-based urology: surrogate endpoints-con[J]. Eur Urol Focus, 2021, 7(6): 1219-1221. DOI: 10.1016/j.euf.2021.10.008.

9. Martini A, Gandaglia G, Briganti A. Evidence-based urology: surrogate endpoints-for[J]. Eur Urol Focus, 2021, 7(6): 1217-1218. DOI: 10.1016/j.euf.2021.09.023.

10. Violette PD, Jewett MAS, Richard PO. Evidence-based urology: trustworthy guidelines[J]. Eur Urol Focus, 2021, 7(6): 1243-1246. DOI: 10.1016/j.euf.2021.10.012.

11. Gonzalez-Padilla DA, Dahm P. Evidence-based urology: understanding GRADE methodology[J]. Eur Urol Focus, 2021, 7(6): 1230-1233. DOI: 10.1016/j.euf.2021.09.014.

12. Puerto Nino AK, van der Worp H, Tikkinen KAO, et al.  Evidence-based urology: understanding heterogeneity in systematic reviews[J]. Eur Urol Focus, 2021, 7(6): 1234-1236. DOI: 10.1016/j.euf.2021.09.024.

13. Bausch K, Cartwright R. Evidence-based urology: when is a study or Meta-analysis big enough?[J]. Eur Urol Focus, 2021, 7(6): 1240-1242. DOI: 10.1016/j.euf.2021.09.021.

14. Godbole P, Wilcox DT, Koyle MA. Practical pediatric urology: an evidence-based approach[M]. Springer Nature, 2020.

15. Dahm P, Kunath F. Evidence-based medicine in urology[J]. World J Urol, 2020, 38(3): 515-516. DOI: 10.1007/s00345-020-03139-6.

16. Dahm P, Dmochowski RR. Evidence-based urology (second edition)[M]. Hoboken, NJ: Wiley-Blackwell, 2018.

17. Sur RL, Dahm P, Evidence-based Urology Working Group. Evidence-based urology in practice: Kaplan-Meier analysis[J]. BJU Int, 2010, 105(10): 1360-1362. DOI: 10.1111/j.1464-410X.2010.09234.x.

18. Zhu Y, Duijvesz D, Rovers MM, et al. Evidence-based urology in practice: publication bias[J]. BJU Int, 2011, 107(2): 337-338. DOI: 10.1111/j.1464-410X.2010. 10068_1.x.

19. Dahm P, Kunath F. Evidence-based medicine in urology[J]. World J Urol, 2020, 38(3): 515-516. DOI:10.1007/s00345-020-03139-6.

20. Sadeghi Bazargani H, Hajebrahimi S. Evidence-based urology: how does a randomized clinical trial achieve its designed goals?[J]. Urol J, 2011, 8(2): 88-96. https://pubmed.ncbi.nlm.nih.gov/21656466/.

21. Canfield SE, Dahm P, Evidence-based Urology Working Group. Evidence-based urology in practice: incorporating patient values in evidence-based clinical decision making[J]. BJU Int, 2010, 105(1): 4-5. DOI: 10.1111/j.1464-410X.2009.08939.x.

22. Canfield SE, Sultan S, Dahm P, et al. Evidence-based urology in practice: randomized controlled trials stopped early for benefit[J]. BJU Int, 2010, 106(7): 962-963. DOI: 10.1111/j.1464-410X.2010.09542.x.

23. Imamura M, Cook J, Maclennan S, et al. Evidence-based urology in practice: heterogeneity in a systematic review Meta-analysis[J]. BJU Int, 2010,105(6):770-3. DOI: 10.1111/j.1464-410X.2009.09163.x.

24. Karl A, Akl EA, Moy ML, et al. Evidence-based urology in practice: loss to follow-up[J]. BJU Int, 2010, 106(1): 24-26. DOI: 10.1111/j.1464-410X.2010.09320.x.

25. Lavallée LT, Dahm P, Breau RH. Evidence-based urology in practice: composite endpoints[J]. BJU Int, 2010, 106(5): 610-612. DOI: 10.1111/j.1464-410X.2010.09455.x.

26. MacDonald SL, Scales CD Jr, Phillip D, et al. Evidence-based urology in practice: P-values vs confidence intervals[J]. BJU Int, 2010, 106(6): 758-759. DOI: 10.1111/j.1464-410X.2010.09503.x.

27. Wang SS, Ou YC, Cheng CL, et al. Evidence-based urology in practice: when to believe a subgroup analysis?[J]. BJU Int, 2010, 105(2): 162-164. DOI: 10.1111/j.1464-410X.2009.09053.x.

28. Philipp Dahm, Roger R. Dmochowski. Evidence-Based Urology(first edition)[M]. Oxford: Blackwell Publishing Ltd, 2010.

29. Breau RH, Fergusson D, Dahm P. Evidence-based urology in practice: number needed to treat[J]. BJU Int, 2009, 104(1): 6-8. DOI: 10.1111/j.1464-410X.2009.08618.x.

30. Singh JC, Dahm P. Evidence-based urology in practice: what are levels of evidence?[J]. BJU Int, 2009, 103(7): 860-861. DOI: 10.1111/j.1464-410X.2009.08429.x.

31. Hajebrahimi S, Dahm P, Buckingham J, et al. Evidence-based urology in practice: the Cochrane Library[J]. BJU Int, 2009, 104(8): 1048-1049. DOI: 10.1111/j.1464-410X.2009.08749.x.

32. Krupski TL, Schardt CM, Fesperman SF, et al. Evidence-based urology in practice: how to use PubMed effectively[J]. BJU Int, 2009, 103(9): 1156-1159. DOI: 10.1111/j.1464-410X.2009. 08541.x.

33. Mazel JW, Dahm P, Evidence-Based Urology Working Group. Evidence-based urology in practice: intention-to-treat analysis[J]. BJU Int, 2009, 104(5): 582-583. DOI: 10.1111/j.1464-410X.2009.08653.x.

34. Scales CD Jr, Zarei M, Dahm P, et al. Evidence-based urology in practice: likelihood ratios[J]. BJU Int, 2009, 104(7): 892-894. DOI: 10.1111/j.1464-410X.2009.08785.x.

35. Moinzadeh A. How to choose and critically evaluate an article in evidence-based urology[J]. Can J Urol, 2008, 15(4): 4143-4146. https://pubmed.ncbi.nlm.nih.gov/18706139/.

36. Panda A, Dorairajan LN, Kumar S. Application of evidence-based urology in improving quality of care[J]. Indian J Urol, 2007, 23(2): 91-96. DOI: 10.4103/0970-1591.32055.

37. 魏强. 泌尿外科与循证医学[J]. 中华泌尿外科杂志, 2003, 24(3): 214-216. [Wei Q. Urology and Evidence-based Medicine[J] .Chin J Urol, 2003, 24(3): 214-216.] DOI: 10.3760/j:issn:1000-6702.2003.03.020.

38. 孙西钊, 曾令奇, 叶章群. 循证医学与泌尿外科临床实践(续完)[J]. 临床泌尿外科杂志, 2002, 17(5): 193-196. [Sun XZ, Zeng LQ, Ye ZQ. Evidence-based medicine and clinical practice in urology[J]. Journal of Clinical Urology, 2002, 17(5): 193-196.] DOI: 10.3969/j.issn.1001-1420.2002.05.001.

39. 孙西钊, 曾令奇, 叶章群. 循证医学与泌尿外科临床实践(续)[J]. 临床泌尿外科杂志, 2002, 17(4): 145-147. [Sun  XZ, Zeng LQ, Ye ZQ. Evidence-based medicine and clinical practice in urology[J]. Journal of Clinical Urology, 2002, 17(4): 145-147.] DOI: 10.3969/j.issn.1001- 1420.2002.04.001.

40. 孙西钊, 曾令奇, 叶章群. 循证医学与泌尿外科临床实践[J].临床泌尿外科杂志, 2002, 17(3): 98-99. [Sun XZ, Zeng LQ, Ye ZQ. Evidence-based medicine and clinical practice in urology[J]. Journal of Clinical Urology, 2002, 17(3): 98-99.] DOI: 10.3969/j.issn.1001-1420.2002.03.002.

41. 金杰, 魏强, 主编. 泌尿外科学, 第3版[M]. 北京: 人民卫生出版社, 2022. [Jin J, Wei Q, ed. Urology, 3rd Edition[M]. Beijing: People's Medical Publishing House, 2022.]

42. Faraday M, Hubbard H, Kosiak B, et al. Staying at the cutting edge: a review and analysis of evidence reporting and grading; the recommendations of the American Urological Association[J]. BJU Int, 2009, 104(3): 294-297.  DOI:10.1111/j.1464-410X.2009.08729.x.

43. Knoll T, Omar MI, Maclennan S, et al. Key steps in conducting systematic reviews for underpinning clinical practice guidelines: methodology of the European Association of Urology[J]. Eur Urol, 2018, 73: 290-300. DOI: 10.1016/j.eururo.2017.08.016.

44. Kranz J, Kunath F, Borgmann H, et al. ["UroEvidence" Centre for knowledge translation of the DGU (German Society of Urology). Summarizing, analysing and making current knowledge available][J]. Urol A, 2014, 53(1): 83-86. DOI:10.1007/s00120-013-3396-x.

45. AUA. Evidence-Based Medicine[EB/OL].[2024-01-15]. https://auau.auanet.org/core.

46. Dahm P, Preminger GM. A users guide to the urological literature: introducing a series of evidence based medicine review articles[J]. J Urol, 2007, 178(4): 1149. DOI: 10.1016/j.juro.2007.06.036.

47. 南方护骨联盟前列腺癌骨转移专家组. 前列腺癌骨转移诊疗专家共识(2023版)[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(3): 201-208. [Southern Bone Protection Alliance Prostate Cancer Bone Metastasis Expert Group. Expert consensus on the diagnosis and treatment of bone metastasis in prostate cancer (2023 edition)[J]. Chinese Journal of Endourology (Electronic Edition), 2023, 17(3): 201-208.] DOI: 10.3877/cma.j.issn.1674-3253.2023.03.001.

48. 邵紫萱, 刘妍, 李丽, 等. 复方石韦片治疗尿路感染有效性及安全性的Meta分析[J]. 中国药师, 2022, 25(9): 1563-1571. [Shao ZX, Liu Y, Li L, et al. Efficacy and safety of urinary tract infections treated with compound shiwei tablets: a Meta-analysis[J]. China Pharmacist, 2022, 25(9): 1563-1571.] DOI: 10.19962/j.cnki.issn1008-049X.2022.09.012.

49. 马嘉, 邢建月, 张宇鹏, 等. 中成药治疗良性前列腺增生有效性和安全性的贝叶斯网状Meta分析[J]. 药物流行病学杂志, 2024, 33(3): 301-318. [Ma J, Xing JY, Zhang YP, et al. Efficacy and safety of Chinese patent medicine in the treatment of benign prostatic hyperplasia: a bayesian network Meta-analysis[J]. Chinese Journal of Pharmacoepidemiology, 2024, 33(3): 301-318.] DOI: 10.12173/j.issn.1005-0698.202312018.

50. 姚舞凤, 杨丽平, 秦子岚, 等. 患者决策辅助工具在终末期肾脏病患者治疗方式选择中应用效果的系统评价[J]. 中国循证医学杂志, 2024, 24 (1): 56-60. [Yao WF, Yang LP, Qin ZL, et al. Efficacy of PDA in the selection of treatment modalities for patients with end-stage renal disease: a systematic review[J]. Chinese Journal of Evidence-based Medicine, 2024, 24 (1): 56-60.] DOI: 10.7507/1672-2531.202307020.

51. The Ottawa Hospital Research Institute. Patient Decision Aids[EB/OL].[2024-01-15]. https://decisionaid.ohri.ca/AZsearch.php?criteria=.

Popular Papers
© 2022 - 2024 Zhongnan Medical Journal Press of Zhongnan Hospital of Wuhan University|Support: Yufu Technology
About NM | Contact us